. 2020 Sep 21;53:e20200472. doi: 10.1590/0037-8682-0472-2020

TABLE 1: Clinical and therapeutic description of patients.

AGE (in years)	COMORBIDITIES/HISTO RY	TREATMENT	OUTCOMES (from the	COMPLICATIONS
			beginning of follow-up to
			being discharged)
37	None	ASA^a	Oligosymptomatic^e on the 10^th day	None
48	Asthma and hypothyroidism	ASA^a + atorvastatin	Oligosymptomatic^e on the 9^th day	None
41	Asthma	ASA^a + atorvastatin	Asymptomatic on the 10^th day	None
39	Hypertension, obesity	ASA^a + atorvastatin + oral amoxicillin (875 mg) potassium clavulanate (125 mg) q8h for 7 days	Oligosymptomatic^e on the 4^th day	RTI^b
58	Hypertension, diabetes mellitus, obesity	ASA^a habitual^c + atorvastatin + oral ceftriaxone 2 g/day intravenous for 6 days + azithromycin 500 mg/day for 5 days	Oligosymptomatic^e on the 2^nd day	RTI^b + hospitalization
52	Diabetes mellitus, coronary artery disease, overweight	ASA^a habitual^c + clopidogrel habitual^c; sinvastatin replaced with atorvastatin	Asymptomatic on the 10^th day	None
55	History of non-Hodgkin lymphoma	ASA^a + atorvastatin	Oligosymptomatic^e on the 7^th day	None
55	Hypertension, obesity	ASA^a + atorvastatin	Asymptomatic on the 7^th day	None
81	Hypertension, diabetes mellitus, ex-smoker	ASA^a + atorvastatin + IV ceftriaxone 2 g/day for 10 days + oral azithromycin 500 mg/day for 5 days	Asymptomatic on the 21^st day	RTI^b+ hospitalization
36	Overweight, ex-smoker, circulation problem in the lower limbs	ASA^a	Asymptomatic on the 14^th day	None
13	None	ASA^a	Asymptomatic on the 11^th day	Hospitalization
63	Hypertension	ASA^a + atorvastatin	Oligosymptomatic^e on the 7^th day	None
60	Hypertension, diabetes mellitus, dyslipidemia, obesity, lower limb varicose veins, ex-smoker	ASA^a+ rosuvastatin habitual^b+ oral nitrofurantoin 100 mg q6h for 7 days	Asymptomatic on the 17^th day	UTI^d
43	Overweight	ASA^a + atorvastatin	Asymptomatic on the 14^th day	None

Clinical, therapeutic, and evolutionary details of each patient Keys: (a) ASA: acetylsalicylic acid; (b) RTI: respiratory tract infection; (c) Habitual: medication that the patient already used routinely before the first visit and was maintained for the treatment of COVID-19; (d) UTI: urinary tract infection (e) Oligosymptomatic: patient presents with residual cough or some degree of olfactory change, but without dyspnea.